A short cut to prevent postoperative atrial fibrillation

Lancet. 2021 Dec 4;398(10316):2052-2053. doi: 10.1016/S0140-6736(21)02435-1. Epub 2021 Nov 14.

Authors

Wim Jan van Boven¹, Joris R de Groot², Jolanda Kluin³

Affiliations

¹ Department of Cardiothoracic Surgery, Amsterdam UMC, AMC, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
² Department of Cardiology, Amsterdam UMC, AMC, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
³ Department of Cardiothoracic Surgery, Amsterdam UMC, AMC, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. Electronic address: j.kluin@amsterdamumc.nl.

PMID: 34788639
DOI: 10.1016/S0140-6736(21)02435-1

No abstract available

Publication types

Comment

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / prevention & control
Coronary Artery Bypass
Humans
Postoperative Period

Substances

Anti-Arrhythmia Agents